BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5158422)

  • 21. Stimulating circulation to end stasis in scleroderma.
    Yuan X; Li JD; Chen WJ; Li ZS; Zhu HT; Liu JW; Zhu MJ
    Chin Med J (Engl); 1981 Feb; 94(2):85-93. PubMed ID: 6786844
    [No Abstract]   [Full Text] [Related]  

  • 22. PUVA treatment in sclerodermatoid spectrum of dermatologic diseases: our initial experience.
    Baum S; Pavlotsky F; Shpiro D; Trau H
    Isr Med Assoc J; 2004 Sep; 6(9):563-4. PubMed ID: 15373320
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic effectiveness of ultrasonics and lidase phonophoresis in various forms of scleroderma].
    Didenko IG
    Vestn Dermatol Venerol; 1978 Jun; (6):76-9. PubMed ID: 354249
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapeutic effectiveness of treatment of patients with scleroderma at the Pyatigorsk Spa].
    Braĭtsev AV; Kessel' VP; Marzeeva GI; Shliapak EA; Angelova VS
    Vestn Dermatol Venerol; 1971 Oct; 45(10):35-9. PubMed ID: 5134075
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on beta-aminopropionitrile in patients with scleroderma.
    Keiser HR; Sjoerdsma A
    Clin Pharmacol Ther; 1967; 8(4):593-602. PubMed ID: 4951976
    [No Abstract]   [Full Text] [Related]  

  • 26. Progestins as treatment in generalized progressive scleroderma.
    Bernstein R
    J Oslo City Hosp; 1971; 21(7):111-5. PubMed ID: 5127433
    [No Abstract]   [Full Text] [Related]  

  • 27. [Dynamics of hydroxyproline content as the indicator of the severity of the course and the effectiveness of treatment of focal scleroderma].
    Fedorova EG; Lashmanova AP
    Vestn Dermatol Venerol; 1978 Dec; (12):18-22. PubMed ID: 570330
    [No Abstract]   [Full Text] [Related]  

  • 28. Avocado/soybean unsaponifiables in the treatment of scleroderma: comment on the article by Maheu et al.
    Jablonska S
    Arthritis Rheum; 1998 Sep; 41(9):1705. PubMed ID: 9751109
    [No Abstract]   [Full Text] [Related]  

  • 29. [Observations of the course of scleroderma after combined Hylase-carnitine therapy].
    Nitzschner H
    Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1108. PubMed ID: 1226844
    [No Abstract]   [Full Text] [Related]  

  • 30. [Conservative treatment of chronic lymphedema and sclerotic skin processes].
    Konopik J
    Z Arztl Fortbild (Jena); 1984; 78(8):307-10. PubMed ID: 6233797
    [No Abstract]   [Full Text] [Related]  

  • 31. [Gestagen therapy of scleroderma. 10 cases].
    Rau R; Pandurovic L; Böni A
    Dtsch Med Wochenschr; 1972 Sep; 97(35):1283-8. PubMed ID: 5050239
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of some sclerosing processes with uropancreozymin].
    Hodác V; Svatos A
    Cesk Dermatol; 1971 Apr; 46(2):83-6. PubMed ID: 5564727
    [No Abstract]   [Full Text] [Related]  

  • 33. [Gestagen therapy in male progressive scleroderma (testicular and mammary changes)].
    Lachner H; Holzmann H; Korting GW
    Arch Klin Exp Dermatol; 1970; 237(2):690-702. PubMed ID: 5447134
    [No Abstract]   [Full Text] [Related]  

  • 34. [Scleroderma in children].
    Beaudoing A; Bost M; Pont J; Dieterlen M
    Pediatrie; 1971; 26(5):529-46. PubMed ID: 5565710
    [No Abstract]   [Full Text] [Related]  

  • 35. [Investigations on the mode of action of D-penicillamine (Metalcaptase) in sclerodermia].
    Daróczy J; Gyöngyvér S
    Munch Med Wochenschr; 1973 Aug; 115(31):1363-7. PubMed ID: 4741080
    [No Abstract]   [Full Text] [Related]  

  • 36. [The prognosis and treatment of scleroderma].
    Degos R
    Rev Prat; 1975 May; 25(25):2003-4, 2005-7. PubMed ID: 1135588
    [No Abstract]   [Full Text] [Related]  

  • 37. [Characteristics of the course of scleroderma in diabetes mellitus].
    Khamaganova IV
    Sov Med; 1990; (2):72-6. PubMed ID: 2356535
    [No Abstract]   [Full Text] [Related]  

  • 38. [Granulomatous panniculitis caused by progestational drugs during the course of progressive scleroderma].
    Cabré J; González JA; Vidal J
    Actas Dermosifiliogr; 1973; 64(9-10):497-504. PubMed ID: 4803670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localized and systemic scleroderma show different histological responses to methotrexate therapy.
    Seyger MM; van den Hoogen FH; van Vlijmen-Willems IM; van de Kerkhof PC; de Jong EM
    J Pathol; 2001 Apr; 193(4):511-6. PubMed ID: 11276011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Scleroderma and dermatomyositis].
    Meinhof W
    Med Welt; 1972 Nov; 23(45):1650-3. PubMed ID: 4637705
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.